The steroid-binding drug colestipol was administered to a patient with digoxin intoxication and the serial digoxin levels were measured. The actual half-life of elimination of digoxin was 55 hours, whereas the predicted half-life calculated from standard pharmacokinetic equations was at least 85 hours. Colestipol presumably interrupts the enterohepatic recycling of digoxin and enhances its fecal excretion. This is the first documented report of the successful use of colestipol for digoxin intoxication.
CaldwellJHClineCT.Biliary excretion of digoxin in man. Clin Pharmacol Ther1976; 19: 410–5.
2.
BazzanoGBazzanoGS.Digitalis intoxication treatment with a new steroid binding resin. JAMA1972; 220: 828–30.
3.
CadyWJRehderTLCampbellJ.Use of cholestyramine resin in the treatment of digitoxin toxicity. Am J Hosp Pharm1979; 36: 92–4.
4.
DohertyJE.Digitalis glycosides. Pharmacokinetics and their clinical implications. Ann Intern Med1973; 79: 229–38.
5.
DettliLOhnausEESpringP.Digoxin dosage in patients with impaired kidney function. Br J Pharmacol1972; 44: 373P.
6.
WagnerJG.Biopharmaceutics and relevant pharmacokinetics, 1st ed. Hamilton, IL: Drug Intelligence, 1971.
7.
JelliffeRWBrookerG.A nomogram for digoxin therapy. Am J Med1974; 57: 63–8.
8.
WellingPGCraigWAKuninCM.Prediction of drug dosage in patients with renal failure using data derived from normal subjects. Clin Pharmacol Ther1975; 18: 45–52.
9.
KoupJRJuskoWJKohliRK.Digoxin pharmacokinetics: role of renal failure in dosage regimen design. Clin Pharmacol Ther1975; 18: 9–21.
